Rocksauce Fiery Hot Pain Relief

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the provision of soothing heat to alleviate discomfort associated with sore muscles and joints.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The lotion should be applied liberally to the area of pain and massaged into the skin until fully absorbed. This application may be repeated 3 to 4 times daily, depending on the severity of symptoms and individual patient response.

For optimal storage, the lotion should be kept at a temperature range of 68° to 77°F (20° to 25°C) to maintain its efficacy.

Contraindications

Use of this product is contraindicated in the following situations:

• The product is not intended for use in children aged 5 years or younger.

• Administration should strictly adhere to the provided directions; any deviation is contraindicated.

• Heating, microwaving, or adding the product to hot water or any container that may cause splattering, leading to burns, is prohibited.

• Direct application to the eyes or mucus membranes is contraindicated.

• Oral ingestion or placement in the nostrils is not permitted.

• Application to wounds or damaged skin is contraindicated.

Warnings and Precautions

For external use only; it is imperative to avoid contact with the eyes, mucous membranes, or broken skin to prevent adverse reactions.

Healthcare professionals should advise patients to consult a doctor and discontinue use if any irritation occurs. Additionally, it is recommended that individuals who are pregnant or breastfeeding seek guidance from a health professional prior to use. Those with sensitive skin should also consult a doctor before initiating treatment to ensure safety and efficacy.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients are reminded to stop using the product and consult their doctor if they experience any irritation.

Side Effects

Patients should be aware that the product is for external use only and must avoid contact with the eyes, mucous membranes, or broken skin. In clinical practice, it is advised that individuals consult a doctor and discontinue use if any irritation occurs.

Additionally, it is recommended that patients seek the advice of a health professional prior to use if they are pregnant or breastfeeding. Those with sensitive skin should also consult a doctor before using the product to mitigate the risk of adverse reactions.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Rocksauce Fiery Hot Pain Relief (methyl salicylate, menthol, capsaicin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 5 years of age should not use this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to seek medical advice to weigh the benefits and risks associated with the use of this medication during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication if they are breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as per established protocols. Consultation with a poison control center or a medical toxicologist may also be beneficial in managing the situation effectively.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for guiding treatment decisions and ensuring patient safety.

Nonclinical Toxicology

No teratogenic effects were reported in the studies conducted. Additionally, there was no increase in fetal malformations observed, indicating a lack of non-teratogenic effects.

Information regarding nonclinical toxicology and animal pharmacology and toxicology was not provided in the insert.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center in the event of accidental ingestion. It is important to emphasize that this product is not intended for use in children aged 5 years or younger.

Patients should be instructed to use the product strictly as directed and to avoid any misuse. They should be cautioned against heating the product, microwaving it, or adding it to hot water, as these actions may lead to splattering and potential burns. Additionally, patients must be informed not to apply the product to the eyes, directly on mucous membranes, or to ingest it by mouth or place it in the nostrils. The product should not be applied to wounds or damaged skin.

Healthcare providers should recommend that patients consult a doctor and discontinue use if any irritation occurs. It is also advisable for patients to seek guidance from a health professional before using the product if they are pregnant or breastfeeding. Furthermore, patients with sensitive skin should be encouraged to consult a doctor prior to use to ensure safety and appropriateness.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 68° to 77°F (20° to 25°C) to maintain its efficacy and integrity. Proper storage conditions should be observed to ensure optimal performance.

Additional Clinical Information

The product is administered topically, with patients advised to apply the lotion liberally to the area of pain and massage until absorbed into the skin. This application can be repeated 3-4 times daily.

Clinicians should counsel patients to consult a doctor and discontinue use if irritation occurs. Additionally, patients should seek advice from a health professional before use if they are pregnant or breastfeeding, or if they have sensitive skin. In the event of accidental ingestion, it is crucial to seek medical help or contact the Poison Control Center immediately.

Drug Information (PDF)

This file contains official product information for Rocksauce Fiery Hot Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)